Clinical trial
Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung…
NCT00281125 · Nevada Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00281125 |
|---|---|
| Title | Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer |
| Official title | A Two-Cohort Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin in Patients With Advanced Non-Small Cell Lung Cancers and Malignant Pleural Mesotheliomas |
| Lead sponsor | Nevada Cancer Institute, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer and Pleural Mesothelioma |
| Intervention type | Drug |
| Interventions | PTK787 and Pemetrexed with or without Cisplatin |
| Enrollment | 20 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2006 |
| Completion | Aug 1, 2008 |
| First posted | Jan 24, 2006 |
| Last update posted | Mar 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: